Moroccan pharmaceutical company Laprophan, one of Africa’s largest, has recorded strong investor interest in its initial public offering, with preliminary demand reaching 15.3 billion dirhams, about seven times the size of the offer, according to Moroccan media. More than 44,000 subscribers took part in the operation, reflecting significant market enthusiasm for the laboratory’s listing on […]
